Axsome Therapeutics (AXSM) Return on Capital Employed Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 6,272.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,272.00 |
| Dec 31, 2025 | 7,098.00 |
| Sep 30, 2025 | 1,318.00 |
| Jun 30, 2025 | 192.00 |
| Mar 31, 2025 | -1,059.00 |
| Dec 31, 2024 | -3,291.00 |
| Sep 30, 2024 | -4,602.00 |
| Jun 30, 2024 | -3,974.00 |
| Mar 31, 2024 | -1,226.00 |
| Dec 31, 2023 | 2,447.00 |
| Sep 30, 2023 | 3,709.00 |
| Jun 30, 2023 | 11,090.00 |
| Mar 31, 2023 | 15,548.00 |
| Dec 31, 2022 | 8,227.00 |
| Sep 30, 2022 | 3,745.00 |
| Jun 30, 2022 | -7,463.00 |
| Mar 31, 2022 | -15,140.00 |
| Dec 31, 2021 | -9,978.00 |
| Sep 30, 2021 | -5,974.00 |
| Jun 30, 2021 | -2,671.00 |
| Mar 31, 2021 | -1,224.00 |
| Dec 31, 2020 | 444.00 |
| Sep 30, 2020 | 5,314.00 |
| Jun 30, 2020 | 785.00 |
| Mar 31, 2020 | 2,966.00 |
| Dec 31, 2019 | 22,058.00 |
| Sep 30, 2019 | 10,507.00 |
| Jun 30, 2019 | -4,673.00 |
| Mar 31, 2019 | -13,367.00 |
| Dec 31, 2018 | -40,682.00 |
| Sep 30, 2018 | -31,571.00 |
| Jun 30, 2018 | -10,051.00 |
| Mar 31, 2018 | -3,116.00 |
| Dec 31, 2017 | 3,027.00 |
| Sep 30, 2017 | 2,826.00 |
| Jun 30, 2017 | 3,703.00 |
| Mar 31, 2017 | 5,595.00 |